Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II
Status:
Completed
Trial end date:
2020-03-03
Target enrollment:
Participant gender:
Summary
The overall goal of this proposal is to conduct a partial double-blind randomized Phase III
clinical trial for primary stroke prevention in children with sickle cell anemia (SCA) in
sub-Saharan Africa.
Phase:
Phase 3
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center
Collaborators:
Aminu Kano Teaching Hospital Barau Dikko Teaching Hospital/Kaduna State University Murtala Muhammed Specialist Hospital National Institute of Neurological Disorders and Stroke (NINDS)